MarketBeat on MSN7h
Humana Gains Despite Medicare Advantage Losses-What's the Catch?
Health insurance giant Humana Inc. (NYSE: HUM) stock initially rose in reaction to its fourth quarter of 2024 earnings report ...
Why CVS Health (CVS) Is Among the Best Performing Healthcare Stocks So Far in 2025
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...
10 Best Performing Healthcare Stocks So Far in 2025
In this article, we will look at the 10 Best Performing Healthcare Stocks So Far in 2025.
CVS Health: One Good Quarter Is Not Enough; Retain Sell
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...
Is It Too Late to Buy CVS Health Stock for the High-Yield Dividend?
Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...
Hosted on MSN3d
CVS Health Post-Q4 Earnings: Is the Stock Worth Buying Now?
As healthcare spending continues to rise and regulatory pressure intensifies, companies like CVS Health CVS find themselves ...
CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...